Bilwadi agada followed by Nalpamaradi oil tropical application in fungal infectio
Phase 3
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2024/04/065927
- Lead Sponsor
- Dr Sushma Ghoolappa Kanavi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient diagnosed with Tinea corporis
Patients aged between 18 to 60 years
Irrespective of sex
Positive mycological findings of less than 30 Percentage of the body surface involvement will be recruited for the study
Exclusion Criteria
Patients undergoing antifungal treatment
Generalized skin conditions such as herpes zoster urticaria pemphigus and psoriasis
Patient with Diabetes mellitus and uncontrolled hypertension
Systemic diseases RA Liver and renal dysfunction
Patient with the treatment of phototherapy and corticosteroids
Hypersensitive patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method primary outcome- decrease in fungal load from 0th day to 21st dayTimepoint: 0th 11th and 21st day
- Secondary Outcome Measures
Name Time Method KANDU Itching <br/ ><br>RAGA Erythema <br/ ><br>PIDAKA Eruption <br/ ><br>ROOKSHATA Dryness <br/ ><br>UTSANNA MANDALA Elevation of lesion <br/ ><br>Timepoint: oth 11th & 21st day